Published eBioMedicine, a study suggests people who experience Long COVID neurocognitive symptoms could be at further risk for neurodegenerative diseases.
A study by researchers in the Renaissance School of Medicine at Stony Brook may serve as a foundational assessment of Long Covid patients in a post-pandemic era